| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 10/27/2004 | EP1469877A2 B-cell lymphoma specific antigen for use in diagnosis and treatment of b-cell malignancies |
| 10/27/2004 | EP1469871A2 Method of treating apoptosis and compositions thereof |
| 10/27/2004 | EP1469870A2 Novel compositions and methods for cancer |
| 10/27/2004 | EP1469769A2 Novel compositions and methods for cancer |
| 10/27/2004 | EP1469741A1 A process for the extraction,purification and enzymatic modification of soy 7s globulin alpha' subunit for use as hypocholesterolemizing agent |
| 10/27/2004 | EP1469717A2 Triple transgenic mouse model of alzheimer's disease |
| 10/27/2004 | EP1349867A4 Dimeric fluorescent polypeptides |
| 10/27/2004 | EP1169057B1 Anti-hiv 1 vaccine comprising the entire or part of the tat hiv-1 protein |
| 10/27/2004 | EP1141022B1 Serine protease inhibitor |
| 10/27/2004 | EP1117690A4 Polymeric hemoglobin mutants |
| 10/27/2004 | EP1107793B1 Dextran-leptin conjugates, pharmaceutical compositions and related methods |
| 10/27/2004 | EP1079860B1 Nicotine immunogen |
| 10/27/2004 | EP1064395A4 Novel molecules of the g protein-coupled heptahelical receptor superfamily and uses therefor |
| 10/27/2004 | EP1027027A4 Therapeutic method |
| 10/27/2004 | EP1012603B1 Functional fragments of hiv-1 vpr protein and methods of using the same |
| 10/27/2004 | EP1005483B1 Methods and compositions for rapid furification of proteasomes and methods of use of components thereof |
| 10/27/2004 | EP1000153B1 Crustacean antimicrobial peptides |
| 10/27/2004 | EP0998577B1 Conjugates of transporter peptides and nucleic acid analogs, and their use |
| 10/27/2004 | EP0994901B1 Method for extracting, identifying, using active principles of marine mollusque shells |
| 10/27/2004 | EP0918854B1 M. tuberculosis complex members mycobacteria specific nucleic acid fragments and their applications for the detection and differential diagnosis of m. tuberculosis complex members |
| 10/27/2004 | EP0918795B1 Antiangiogenic drug to treat cancer, arthritis and retinopathy |
| 10/27/2004 | EP0871885B1 Attachment enhanced 293 cells |
| 10/27/2004 | EP0845270B1 Functional fragment antigen of tetanus toxin and tetanus vaccine |
| 10/27/2004 | EP0763107B1 Pantropic neurotrophic factors |
| 10/27/2004 | EP0717108B1 Recombinant prrs proteins, diagnostic kits and vaccines containing said recombinant proteins |
| 10/27/2004 | CN1541335A EPF receptor assays, compounds and therapeutic compsns. |
| 10/27/2004 | CN1541334A Cardiovascular safety assay |
| 10/27/2004 | CN1541273A Monocdyledon plant cells and plants which synthesise modified starch |
| 10/27/2004 | CN1541269A Human protooncogene KG-zo and protein encoded therein |
| 10/27/2004 | CN1541266A FCE fusion proteins for treatment of allergy and asthma |
| 10/27/2004 | CN1541263A Improved methods for binding AcmA-type protein anchor fusions to cell-wall material of micro-organisms |
| 10/27/2004 | CN1541225A Humanized antibodies that recognize beta amyloid peptide |
| 10/27/2004 | CN1541223A Expression of functional human olfactory cyclic nucleotide gated (CNG)channel in recombinant host cells and use thereof in cell based assays to identify smell modulators |
| 10/27/2004 | CN1541222A Antibodies to non-functional P 2 Chi 7 receptor diagnosis and treatment of cancers and other conditions |
| 10/27/2004 | CN1541221A Moringa seed proteins |
| 10/27/2004 | CN1541111A Mutant forms of cholera holotoxin as adjuvant |
| 10/27/2004 | CN1541107A Growth factor complex |
| 10/27/2004 | CN1541102A Somatostain agonists |
| 10/27/2004 | CN1541068A Method for prepn. of gliadin-and glutenin-rich fractions out of gluten in aqueous medium and in presence of acid |
| 10/27/2004 | CN1539978A Expression vector, engineering bacteria of N* deacetylating Alpha 1 monomer of human thymosin, and preparation method |
| 10/27/2004 | CN1539974A MITEs like element and transcriptional activation element |
| 10/27/2004 | CN1539972A cDNA segment of controlling growth of microspore of paddy, coded result and application |
| 10/27/2004 | CN1539970A Heterophil neutral leucocyte factor alpha |
| 10/27/2004 | CN1539969A Gene of prawn and coded polypeptide |
| 10/27/2004 | CN1539968A An allelomorphic gene of gene LAPTM 4B relevant to liver cancer of human, coded result and application |
| 10/27/2004 | CN1539962A Method for separating silk gland cell of silkworm suited to researches in molecular biology |
| 10/27/2004 | CN1539848A Method for purifying recombined human interferon alpha-2b by using affinity chromatography of expanded bed pigment |
| 10/27/2004 | CN1173037C Single-chain bifunctional glycoprotein hormones |
| 10/27/2004 | CN1173036C Whole-length gene sequence of donkey leucocytic hyptoxic vaccine strain for horse's infectious anemia (EIAV) |
| 10/27/2004 | CN1173035C Cotton leaf curl virus (CLCuV) promoter and its use |
| 10/27/2004 | CN1173034C TSA 305 gene |
| 10/27/2004 | CN1173033C Modulator of TNF/NGF superfamily receptors and soluble oligomeric TNF/NGF superfamily receptors |
| 10/27/2004 | CN1173030C Process for transforming antibacterial peptide AD gene by yeast fermentation |
| 10/27/2004 | CN1172956C Mutational human gene nucleotide sequence coded polypeptide and its applications |
| 10/27/2004 | CN1172955C Fluorescin |
| 10/27/2004 | CN1172954C High-expression gene of liver cancer, proteni coded by it and its application |
| 10/27/2004 | CN1172953C Gene sequence and amino-acid sequence of varient omega-conch toxin polypeptide and their preparing method and medicinal use |
| 10/27/2004 | CN1172952C Mannosan peptide and its prepn and use |
| 10/27/2004 | CN1172717C Method for treating AIDS and its preparing method |
| 10/26/2004 | US6809239 Choline monooxygenase gene |
| 10/26/2004 | US6809234 Scarecrow gene, promoter and uses thereof |
| 10/26/2004 | US6809233 Nucleotide sequences coding transport protein for use as tool in the transport of proteins in cells |
| 10/26/2004 | US6809191 GM-CSF nucleic acid sequences |
| 10/26/2004 | US6809189 Apoptin-associating protein |
| 10/26/2004 | US6809183 Polypeptide for use in the generation of disease resistant plants |
| 10/26/2004 | US6809182 Utlizing the varicella-zoster virus protein's ability to enter and exit eukaryotic cells for drug or secreting agent delivery |
| 10/26/2004 | US6809181 Human beta-defensin-3 (HBD-3), a highly cationic beta-defensin antimicrobial peptide |
| 10/26/2004 | US6809180 Compositions and methods for screening antimicrobials |
| 10/26/2004 | US6809179 Immunogenic peptides used in immunotherapy of cancers/tumors; immunostimulants |
| 10/26/2004 | US6809178 Polypeptide for use in the treatment of addison's disease |
| 10/26/2004 | US6809175 Cadherin derived growth factor and its use |
| 10/26/2004 | US6809078 Nucleotide sequences coding polypeptide use in the generation of insect resistant plants; biological pest control |
| 10/26/2004 | US6809075 To enhance the elasticity and/or appearance; low molecular weights; used in combination with retinoids, preferably tretinoin |
| 10/26/2004 | US6808922 Retroviral vectors comprising a functional splice donor site and a functional splice acceptor site |
| 10/26/2004 | US6808905 Lentiviral vectors encoding clotting factors for gene therapy |
| 10/26/2004 | US6808902 Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules |
| 10/26/2004 | US6808900 Test kits; genetic engineering |
| 10/26/2004 | US6808899 G protein-coupled receptor protein for use in treatment of nervous system disorders |
| 10/26/2004 | US6808898 Low oxygen affinity mutant hemoglobins |
| 10/26/2004 | US6808893 Glutamate transporter associated proteins and methods of use thereof |
| 10/26/2004 | US6808891 Modulators of the function of FAS/APO1 receptors |
| 10/26/2004 | US6808890 Method of detecting a cancerous cell expressing EGFL6, and EGF mutif protein |
| 10/26/2004 | US6808878 Genes from the 20Q13 amplicon and their uses |
| 10/26/2004 | US6808877 Ligands for FPR class receptors that induce a host immune response to a pathogen or inhibit HIV infection |
| 10/26/2004 | US6808876 Cellular regulators of infectious agents and methods of use |
| 10/26/2004 | US6808714 Nucleotide sequences for use in the detection of microorganismal infections |
| 10/26/2004 | US6808713 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 10/26/2004 | US6808712 Imunogenic a beta fragment linked to immunoglobulin carrier to form conjugate; adjuvant comprising antibodies to a beta fragment enhances immune response; alzheimer*s disease treatment |
| 10/26/2004 | US6808711 Immunologically active proteins from Borrelia burgdorferi, nucleic acids which encode them, and their use in test kits and as vaccines |
| 10/26/2004 | US6808710 Contacting cell expressing pd-1 with binding agent; genetic transduction of negative signal |
| 10/26/2004 | US6808709 Immunoglobulins containing protection proteins and their use |
| 10/26/2004 | US6808706 Method for keeping the quality of aqueous parenteral solution of thrombomodulin in storage and distribution |
| 10/26/2004 | CA2328060C Gene any-rf, dormancy-control substance and method for preparing the same as well as cell-control agent for biological cells |
| 10/26/2004 | CA2261999C Invertase inhibitor |
| 10/26/2004 | CA2217122C Medical composition for curing thrombocytopenia |
| 10/26/2004 | CA2142973C A methodology for selecting superagonists, antagonists and superantagonists of hormones whose receptor complex includes gp 130 |
| 10/26/2004 | CA2137237C Purified forms of dnase |
| 10/26/2004 | CA2080462C Therapeutic uses of actin-binding compounds |
| 10/26/2004 | CA1341461C T helper cell growth factor |
| 10/22/2004 | CA2465017A1 Reagents for detecting efavirenz |